GREAT NEWS!

Out of more than 500 applicants and 10 finalists, INMED Partnerships for Children was selected as one of 5 for the Saving Lives at Birth Grand Challenge, which funds innovative approaches to reducing maternal/neonatal mortality rates.

Roughly 2.7 million babies die annually—most from preventable causes? Neonatal jaundice can be one of those causes. If left untreated, it can lead to irreparable damage and even death.

INMED is partnering with Little Sparrows Technologies to implement the Bilikit(TM), a combination of simple and portable innovations to screen for, diagnose and treat neonatal jaundice in developing regions. This approach is critical in Peru, where more than 90% of health facilities lack the equipment and training to adequately diagnose and treat neonatal jaundice, contributing to a rate of jaundice-linked brain damage (kernicterus) 10 to 20 times higher than in high-income countries.

We use cookies to improve your experience on our websites. By continuing you are giving consent to cookies being used. For more information on cookies and how to manage them, see our cookie policy at the link below. Allow CookiesPrivacy Policy